BARAULT, LUDOVIC
 Distribuzione geografica
Continente #
NA - Nord America 2.392
EU - Europa 2.385
AS - Asia 1.600
SA - Sud America 41
OC - Oceania 32
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.477
Nazione #
US - Stati Uniti d'America 2.297
CN - Cina 1.073
IT - Italia 819
RU - Federazione Russa 490
GB - Regno Unito 157
DE - Germania 151
FR - Francia 121
JP - Giappone 107
SE - Svezia 106
IE - Irlanda 88
ES - Italia 79
CA - Canada 71
HK - Hong Kong 71
IN - India 65
SG - Singapore 57
TW - Taiwan 57
FI - Finlandia 51
KR - Corea 47
PL - Polonia 42
NL - Olanda 40
UA - Ucraina 40
VN - Vietnam 35
BE - Belgio 32
AU - Australia 31
DK - Danimarca 30
CH - Svizzera 29
BR - Brasile 23
MX - Messico 23
AT - Austria 22
GR - Grecia 17
AM - Armenia 16
PT - Portogallo 15
IL - Israele 14
HU - Ungheria 13
NO - Norvegia 10
TR - Turchia 10
RO - Romania 9
AR - Argentina 7
MY - Malesia 7
BA - Bosnia-Erzegovina 6
BN - Brunei Darussalam 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
IR - Iran 6
ZA - Sudafrica 6
CO - Colombia 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
ID - Indonesia 4
PH - Filippine 4
TN - Tunisia 4
BY - Bielorussia 3
ET - Etiopia 3
SA - Arabia Saudita 3
TH - Thailandia 3
BG - Bulgaria 2
CL - Cile 2
EC - Ecuador 2
EU - Europa 2
HR - Croazia 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
HN - Honduras 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 6.477
Città #
Ann Arbor 378
Beijing 212
Chandler 168
Shanghai 142
Torino 117
Fairfield 102
Redwood City 102
Guangzhou 92
Dublin 83
Houston 78
Woodbridge 69
Ashburn 67
Milan 65
Seattle 62
Nanjing 60
Cambridge 57
Hangzhou 57
Wilmington 55
Dearborn 52
Nyköping 49
Rome 43
Jacksonville 35
Medford 34
Tokyo 34
Turin 32
Taipei 31
Pisa 29
Villeurbanne 27
Singapore 26
London 25
New York 25
Wuhan 25
Tianjin 23
Princeton 22
Lappeenranta 21
Warsaw 21
Boston 20
Galveston 19
Central 18
Los Angeles 18
Shenyang 18
Fremont 17
Harbin 17
Chengdu 16
Zhengzhou 15
Barcelona 14
Changsha 14
Dong Ket 14
Hong Kong 14
Boardman 13
Brussels 13
Helsinki 13
Ottawa 13
Yerevan 13
Duncan 12
Palermo 12
Rotterdam 12
Toronto 12
Central District 11
Melbourne 11
New Haven 11
Paris 11
Serio 11
Buffalo 10
Chicago 10
Jinan 10
Munich 10
Odense 10
Phoenix 10
San Diego 10
Bologna 9
Bolzano 9
Chennai 9
Norwalk 9
San Francisco 9
Simi Valley 9
Trieste 9
Vienna 9
Xian 9
Rehovot 8
San Mateo 8
Bari 7
Berlin 7
Bethesda 7
Copenhagen 7
Fuzhou 7
Genoa 7
Krakow 7
Lyngby 7
Madrid 7
Manchester 7
Nanning 7
Oslo 7
Seoul 7
Shenzhen 7
Wenzhou 7
Antwerpen 6
Bandar Seri Begawan 6
Birmingham 6
Brookline 6
Totale 3.198
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.771
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer 1.048
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 549
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients 544
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase 523
MGMT methylation assessed by methyl-BEAMing technique is a prognostic and predictive biomarker in glioblastoma and metastatic colorectal cancer patients 357
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 263
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients 212
Evolving neoantigen profiles in colorectal cancers with DNA repair defects 198
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 192
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor 149
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer 140
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer 110
MET-driven resistance to dual EGFR and BRAF blockade may be overcome by switching from EGFR to MET inhibition in BRAF mutated colorectal cancer 108
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib. 96
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 63
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients 58
Ras Mutations in Cancer 53
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation 51
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 49
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients 43
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 33
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 14
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 9
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 9
Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 5
Totale 6.647
Categoria #
all - tutte 12.543
article - articoli 0
book - libri 0
conference - conferenze 323
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020735 0 60 79 66 44 55 53 73 95 94 72 44
2020/20211.023 47 43 52 75 104 85 93 63 95 130 87 149
2021/20221.135 134 138 120 159 67 56 64 54 71 48 123 101
2022/20231.444 67 72 51 94 68 135 68 89 593 63 71 73
2023/2024886 79 83 66 58 82 69 94 87 27 88 71 82
2024/202576 43 33 0 0 0 0 0 0 0 0 0 0
Totale 6.647